Association of ANRIL Expression with Coronary Artery Disease in Type 2 Diabetic Patients

Esmaeil Rahimi1, Amirhossein Ahmadi1, Mohammad Ali Boroumand2

  • 1Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

Cell Journal
|January 9, 2018
PubMed
Abstract

Insights

Antisense noncoding RNA in INK4 locus (ANRIL) expression is elevated in type 2 diabetes mellitus (T2DM) patients with coronary artery disease (CAD). ANRIL may serve as a biomarker for detecting CAD in diabetic individuals.

Area of Science:

  • Genetics and Molecular Biology
  • Cardiovascular Disease Research
  • Endocrinology and Metabolism

Background:

  • The INK4 locus harbors the ANRIL gene, a key player in various diseases including coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM).
  • ANRIL expression is frequently altered in immune-mediated conditions, and CAD significantly impacts T2DM patient mortality.
  • Understanding ANRIL's role in T2DM patients with CAD is crucial for identifying potential diagnostic markers.

Purpose of the Study:

  • To investigate and compare ANRIL gene expression levels in T2DM patients, differentiating between those with and without CAD.
  • To evaluate ANRIL as a potential biomarker for CAD in the context of type 2 diabetes.

Main Methods:

  • A case-control study design was employed.
  • ANRIL expression was quantified using quantitative reverse transcription-polymerase chain reaction (RT-qPCR) in peripheral blood mononuclear cells.
  • The study included 64 T2DM patients, categorized into CAD-positive (n=33) and CAD-negative (n=31) groups based on coronary angiography.

Main Results:

  • ANRIL expression was significantly upregulated (2.34-fold, P=0.012) in T2DM patients with CAD compared to those without CAD.
  • Receiver operating characteristic (ROC) curve analysis indicated that ANRIL has potential as a biomarker for CAD detection in diabetic patients.

Conclusions:

  • Elevated ANRIL expression levels are associated with the presence of CAD in patients with type 2 diabetes mellitus.
  • ANRIL demonstrates potential as a peripheral biomarker for identifying coronary artery disease in diabetic individuals.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
430
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
736